<![CDATA[Real-World CAR-T Comparisons: Axi-cel vs Liso-cel in 2L LBCL]]>

Summary: Doctors from 15 hospitals across the US compared three different CAR-T cell therapies for treating a type of blood cancer called large B-cell lymphoma. They looked closely at two main treatments: axi-cel and liso-cel. Both treatments worked about the same when it came to fighting the cancer. However, axi-cel was faster to make and had fewer manufacturing mistakes, but it caused more severe side effects like nerve issues and immune system overreactions. On the other hand, liso-cel had much milder side effects. The doctors also talked about how patients need better care after treatment to help fight off infections and keep their immune systems strong.

For more details, see cancernetwork at cancernetwork.com/view/real-world-car-t-comparisons-axi-cel-vs-liso-cel-in-2l-lbcl (opens in new tab)